Unlock The Potential of MIR135A2: A Promising Drug Target and Biomarker

Unlock The Potential of MIR135A2: A Promising Drug Target and Biomarker

MIR135A2 (hsa-miR-135a-2-3p) is a non-coding RNA molecule that has been identified as a potential drug target and biomarker for various diseases, including cancer. Its unique structure and expression pattern make it an attractive target for researchers to study and develop new therapeutic approaches.

MIR135A2 is a microRNA (miRNA), a small non-coding RNA molecule that plays a crucial role in post-transcriptional gene regulation. It is expressed in a variety of tissues and cells and is involved in regulating gene expression, cell growth, and differentiation.

One of the key features of MIR135A2 is its unique structure. It consists of 29 amino acid residues and has a partial amino acid sequence of Val-Glu-Asp-Glu-Asp-Glu-Asp-Glu-Asp-Glu-Asp-Glu . This structure is unique among miRNAs and has been identified as a potential drug target.

MIR135A2 has been shown to play a role in a variety of diseases, including cancer. For example, studies have shown that MIR135A2 is downregulated in various types of cancer, including breast, ovarian, and prostate cancer. Additionally, MIR135A2 has been shown to be involved in cell survival and proliferation, which are important factors in the development and progression of cancer.

Another potential mechanism by which MIR135A2 may contribute to cancer development is its role in regulating apoptosis, or cell death. Studies have shown that MIR135A2 has been shown to promote apoptosis in cancer cells, which may contribute to their poor prognosis.

MIR135A2 has also been shown to play a role in regulating inflammation, which is a major contributor to the development and progression of many diseases, including cancer. For example, studies have shown that MIR135A2 is involved in the regulation of toll-like receptor 4 ( TLR4), which is a key regulator of inflammation.

In addition to its potential role in cancer, MIR135A2 has also been shown to have potential therapeutic applications in other diseases. For example, studies have shown that MIR135A2 can be used as a potential therapeutic agent for treating neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease. Additionally, MIR135A2 has been shown to have potential applications in treating diseases of the respiratory system, such as asthma and chronic obstructive pulmonary disease (COPD).

In conclusion, MIR135A2 is a unique and promising drug target and biomarker for a variety of diseases. Its unique structure and expression pattern make it an attractive target for researchers to study and develop new therapeutic approaches. Further research is needed to fully understand the role of MIR135A2 in disease and to develop effective therapies based on it.

Protein Name: MicroRNA 135a-2

More Common Targets

MIR135B | MIR136 | MIR137 | MIR137HG | MIR138-1 | MIR138-2 | MIR139 | MIR140 | MIR141 | MIR142 | MIR143 | MIR144 | MIR145 | MIR1468 | MIR1469 | MIR146A | MIR146B | MIR1470 | MIR1471 | MIR147A | MIR147B | MIR148A | MIR148B | MIR149 | MIR150 | MIR151A | MIR151B | MIR152 | MIR153-1 | MIR153-2 | MIR1537 | MIR1538 | MIR1539 | MIR154 | MIR155 | MIR155HG | MIR1587 | MIR15A | MIR15B | MIR16-1 | MIR16-2 | MIR17 | MIR17HG | MIR181A1 | MIR181A1HG | MIR181A2 | MIR181A2HG | MIR181B1 | MIR181B2 | MIR181C | MIR181D | MIR182 | MIR1825 | MIR1827 | MIR183 | MIR184 | MIR185 | MIR186 | MIR187 | MIR188 | MIR18A | MIR18B | MIR1908 | MIR1909 | MIR190A | MIR190B | MIR191 | MIR1910 | MIR1911 | MIR1912 | MIR1913 | MIR1914 | MIR1915 | MIR1915HG | MIR192 | MIR193A | MIR193B | MIR193BHG | MIR194-1 | MIR194-2 | MIR194-2HG | MIR195 | MIR196A1 | MIR196A2 | MIR196B | MIR197 | MIR1972-1 | MIR1972-2 | MIR1973 | MIR1976 | MIR198 | MIR199A1 | MIR199A2 | MIR199B | MIR19A | MIR19B1 | MIR19B2 | MIR200A | MIR200B | MIR200C